EUVIMEDEUVIMED entdecken
Crossref

Frequency of CCR5-Δ32, CCR2-64I, and SDF1-3′A Mutations in People with HIV Diagnoses and HIV Negative Participant in Khuzestan Province, Iran

Mina Bavi, Shahram Jalilian, Mehdi Bijanzadeh, Roohangiz Nashibi, Azarakhsh Azaran iD

AIDS Research and Human Retroviruses · 2026

DOI: 10.1177/08892229251405792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2026. Verfasst von Mina Bavi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Chemokine CXCL12, Receptors, CCR2, Receptors, CCR5, HIV Infections. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human immunodeficiency virus type 1 (HIV-1) binds to CD4 receptors. Chemokine receptors such as C-C chemokine receptor type 5 (CCR5), C-C chemokine receptor type 2 (CCR2), and stromal-derived factor (SDF1) are involved in HIV cell entry, and mutations in the genes encoding these chemokine receptors and their ligands may play a role against HIV and acquired immunodeficiency syndrome (AIDS) progression. This study aims to investigate the frequency of the above polymorphisms within the Iranian population, evaluating their contribution to a protective genetic background against HIV acquisition and progression. Two hundred eighty-five healthy individuals and 100 people with HIV were selected. CCR5 genotyping was performed by polymerase chain reaction (PCR). CCR2 and SDF-1 polymorphism were analyzed by tetra-primer amplification refractory mutation system-polymerase chain (Tetra-ARMS-PCR). No CCR5-Δ32 mutants were found in either group. The screening for the CCR2 polymorphism yielded 44 (44%) and 127 (44.6%) heterozygous genotypes in the people with HIV and healthy individuals. Homozygous mutants were seen in 1 (1%) and 28 (9.8%) of the people living with HIV and healthy individuals, respectively, revealing a CCR2-64I allele frequency of 29.7%. CCR2-64I is associated with HIV resistance and reduced AIDS progression ( p- value = .018). Among our 385 analyzed samples, 2 (2%) and 12 (4.2%) were found to be SDF1 heterozygous in persons with HIV and healthy individuals, respectively. Three (3%) of the people with HIV and 25 (8.8%) of the healthy individuals carried homozygous mutant variants. The allele frequency of the above polymorphism reached 9.1%, but no statistically significant association was observed, albeit it is borderline ( p- value = .062). There are different distributions between people with HIV and healthy individuals, suggesting that CCR2-64I and SDF1-3′A may have a protective effect on HIV and that CCR2-64I (genotype I/I) has an effect on protecting against HIV and delaying progression from HIV status to AIDS. It could be used for prognostic genotyping in people with HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL12Receptors, CCR2Receptors, CCR5HIV InfectionsHumansIranMaleFemaleAdultGenotypeMiddle AgedGene FrequencyMutationYoung AdultPolymerase Chain ReactionPolymorphism, Genetic

Stichwörter der Autor:innen

AIDSCCR2-64ICCR5-Δ32HIV-1SDF1-3′Apolymorphism

Substanzen

Chemokine CXCL12Receptors, CCR2Receptors, CCR5CCR2 protein, humanCCR5 protein, humanCXCL12 protein, human

Autor:innen und Institutionen

  • Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Medical Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Infectious Diseases, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Azarakhsh Azaran

Zitieren

APA

Bavi, M., Jalilian, S., Bijanzadeh, M., Nashibi, R., & Azaran, A. (2026). Frequency of CCR5-Δ32, CCR2-64I, and SDF1-3′A Mutations in People with HIV Diagnoses and HIV Negative Participant in Khuzestan Province, Iran. AIDS Research and Human Retroviruses. https://doi.org/10.1177/08892229251405792

Vancouver

Bavi M, Jalilian S, Bijanzadeh M, Nashibi R, Azaran A. Frequency of CCR5-Δ32, CCR2-64I, and SDF1-3′A Mutations in People with HIV Diagnoses and HIV Negative Participant in Khuzestan Province, Iran. AIDS Research and Human Retroviruses. 2026. doi:10.1177/08892229251405792

BibTeX
@article{Bavi2026,
  author = {Bavi, Mina and Jalilian, Shahram and Bijanzadeh, Mehdi and Nashibi, Roohangiz and Azaran, Azarakhsh},
  title = {Frequency of CCR5-Δ32, CCR2-64I, and SDF1-3′A Mutations in People with HIV Diagnoses and HIV Negative Participant in Khuzestan Province, Iran},
  journal = {AIDS Research and Human Retroviruses},
  year = {2026},
  doi = {10.1177/08892229251405792}
}
Kostenlos starten →